← Leaderboards
Darrick Carter
Pai Life Sciences, Inc.
$5,698,987
Attributed
$5,698,987
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2013–22$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,698,987 · 5
By mechanism
N44$4,448,622 · 2
N43$1,250,365 · 3
Top collaborators
No co-investigators on record.
Most similar at Pai Life Sciences, Inc.
Same institution · by research overlap
- Darrick Albert Carter$10,984,674
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesDisorder ControlPharmaceutical PreparationsDrug EfficacyOnchocerciasisAnimalsAerosolizedProphylacticDrug KineticsDrug FormulationsToxic EffectClinical TrialsClinical ResearchContractorEnsureCervarixAnimal ModelBypassBreathingAnalogDrug CombinationsEffectivenessDoseBase
Grant awards (5)
LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS$597,953
N43 · FY2022 · AI · contact PI
Phase II - Development of a Prophylactic Onchocerciasis Vaccine$2,961,685
N44 · FY2019 · AI · contact PI
DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE$441,905
N43 · FY2016 · AI · contact PI
INHALED DRUG COMBINATION FOR TUBERCULOSIS THERAPY$1,486,937
N44 · FY2015 · AI · contact PI
IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs$210,507
N43 · FY2013 · AI · contact PI